Story perspectives

Nanobodies Show Promise for Treating Brain Disorders

11/9/2025

44 5

Summary

Story summary

A study published on November 5 shows nanobodies cross the blood-brain barrier more effectively than traditional antibodies, potentially enabling treatments for brain disorders such as Alzheimer's and schizophrenia with fewer side effects.
Researchers from the Centre National de la Recherche Scientifique (CNRS) emphasize that further studies on stability and safety are needed before human trials can begin.
They aim to develop clinical-grade formulations that maintain efficacy during storage.

1 of 1

Story summary

A study published on November 5 shows nanobodies cross the blood-brain barrier more effectively than traditional antibodies, potentially enabling treatments for brain disorders such as Alzheimer's and schizophrenia with fewer side effects.
Researchers from the Centre National de la Recherche Scientifique (CNRS) emphasize that further studies on stability and safety are needed before human trials can begin.
They aim to develop clinical-grade formulations that maintain efficacy during storage.